Giedrius Kalesnykas

1.4k total citations
56 papers, 1.1k citations indexed

About

Giedrius Kalesnykas is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Giedrius Kalesnykas has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Ophthalmology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Giedrius Kalesnykas's work include Retinal Diseases and Treatments (15 papers), Glaucoma and retinal disorders (11 papers) and Retinal Development and Disorders (11 papers). Giedrius Kalesnykas is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Glaucoma and retinal disorders (11 papers) and Retinal Development and Disorders (11 papers). Giedrius Kalesnykas collaborates with scholars based in Finland, United States and Lithuania. Giedrius Kalesnykas's co-authors include Hannu Uusitalo, Riitta Miettinen, Frances E. Cone, Ericka Oglesby, Mary Ellen Pease, Matthew R. Steinhart, Harry A. Quigley, Donald J. Zack, Jukka Puoliväli and Kai Kaarniranta and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Giedrius Kalesnykas

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giedrius Kalesnykas Finland 19 483 410 176 143 142 56 1.1k
Samantha Carreiro United States 11 427 0.9× 266 0.6× 57 0.3× 89 0.6× 101 0.7× 21 827
Covadonga Pañeda Spain 17 482 1.0× 90 0.2× 58 0.3× 66 0.5× 166 1.2× 29 981
Marcus Karlstetter Germany 20 977 2.0× 893 2.2× 262 1.5× 105 0.7× 230 1.6× 38 2.0k
Xiaoxi Qiao United States 20 1.2k 2.4× 434 1.1× 137 0.8× 64 0.4× 699 4.9× 44 1.9k
Vicki Chrysostomou Australia 19 956 2.0× 951 2.3× 296 1.7× 53 0.4× 207 1.5× 37 1.5k
Louis DeSantis United States 23 644 1.3× 957 2.3× 262 1.5× 19 0.1× 223 1.6× 41 1.4k
Alberto Triviño Spain 23 829 1.7× 1.3k 3.1× 405 2.3× 36 0.3× 212 1.5× 34 1.9k
Jorge L. Cueva Vargas Canada 12 745 1.5× 838 2.0× 228 1.3× 36 0.3× 180 1.3× 18 1.3k
Evan B. Stubbs United States 20 376 0.8× 109 0.3× 80 0.5× 22 0.2× 281 2.0× 52 925

Countries citing papers authored by Giedrius Kalesnykas

Since Specialization
Citations

This map shows the geographic impact of Giedrius Kalesnykas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giedrius Kalesnykas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giedrius Kalesnykas more than expected).

Fields of papers citing papers by Giedrius Kalesnykas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giedrius Kalesnykas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giedrius Kalesnykas. The network helps show where Giedrius Kalesnykas may publish in the future.

Co-authorship network of co-authors of Giedrius Kalesnykas

This figure shows the co-authorship network connecting the top 25 collaborators of Giedrius Kalesnykas. A scholar is included among the top collaborators of Giedrius Kalesnykas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giedrius Kalesnykas. Giedrius Kalesnykas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalesnykas, Giedrius, et al.. (2024). A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model. PLoS ONE. 19(8). e0308671–e0308671. 1 indexed citations
3.
Ahmed, Zubair, et al.. (2022). Structure–Function Relationships in the Rodent Streptozotocin-Induced Model for Diabetic Retinopathy: A Systematic Review. Journal of Ocular Pharmacology and Therapeutics. 38(4). 271–286. 18 indexed citations
4.
Takeda, Akira, Simon Kaja, Christa E. Müller, et al.. (2022). CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity. Cellular and Molecular Life Sciences. 79(3). 152–152. 5 indexed citations
6.
Ulčinas, Artu̅ras, et al.. (2021). Introducing an Efficient In Vitro Cornea Mimetic Model for Testing Drug Permeability. SHILAP Revista de lepidopterología. 3(3). 30–30. 3 indexed citations
7.
Järvinen, Tero A.H., et al.. (2020). Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents. Journal of Visualized Experiments. 8 indexed citations
9.
Kaja, Simon, et al.. (2018). <em>In Vivo</em> Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model. Journal of Visualized Experiments. 6 indexed citations
10.
Leinonen, Henri, Velta Keksa-Goldsteine, Ekaterina Savchenko, et al.. (2017). Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy. Scientific Reports. 7(1). 1597–1597. 50 indexed citations
11.
Kalesnykas, Giedrius, et al.. (2016). Age-related differences in light sensitivity in BALB/c mice. Investigative Ophthalmology & Visual Science. 57(12). 5004–5004. 1 indexed citations
12.
Uusitalo‐Järvinen, Hannele, et al.. (2016). Intravitreal injection of PBS reduces retinal neovascularization in the mouse oxygen-induced retinopathy model. Investigative Ophthalmology & Visual Science. 57(12). 3649–3649. 1 indexed citations
13.
Hakkarainen, Jenni J., et al.. (2016). Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells. International Journal of Pharmaceutics. 511(1). 73–78. 22 indexed citations
14.
Vaajanen, Anu, Jooseppi Puranen, Giedrius Kalesnykas, Heikki Vapaatalo, & Hannu Uusitalo. (2014). Neuroprotective Effects of Mas-receptor Ligands in an Experimental Rat Glaucoma. 114–122. 1 indexed citations
15.
Kalesnykas, Giedrius, et al.. (2012). Twelve-week Streptozotocin-induced Diabetes In Rats Does Not Cause Significant Retinal Degeneration, But Upregulates Heat Shock Protein Response. Investigative Ophthalmology & Visual Science. 53(14). 5400–5400. 1 indexed citations
16.
Kalesnykas, Giedrius, Ericka Oglesby, Donald J. Zack, et al.. (2012). Retinal Ganglion Cell Morphology after Optic Nerve Crush and Experimental Glaucoma. Investigative Ophthalmology & Visual Science. 53(7). 3847–3847. 101 indexed citations
17.
Rönkkö, Seppo, et al.. (2011). BDNF-deficiency Downregulates SIRT1 and Upregulates SIRT2 Expression in Aging Mouse Retina. Investigative Ophthalmology & Visual Science. 52(14). 2697–2697. 1 indexed citations
18.
Oglesby, Ericka, Harry A. Quigley, Donald J. Zack, et al.. (2011). Semi-automated, quantitative analysis of retinal ganglion cell morphology in mice selectively expressing yellow fluorescent protein. Experimental Eye Research. 96(1). 107–115. 16 indexed citations
19.
Kalesnykas, Giedrius, et al.. (2008). Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models. Neuroscience. 155(3). 937–947. 65 indexed citations
20.
Kalesnykas, Giedrius, Jukka Puoliväli, Jouni Sirviö, & Riitta Miettinen. (2004). Cholinergic neurons in the basal forebrain of aged female mice. Brain Research. 1022(1-2). 148–156. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026